Tecan Symposium 2008 in Zürich, Switzerland
Biologics - From Benchtop to Production
Tecan has been pleased to host its second annual scientific symposium in Zürich Switzerland. The Tecan Symposium offers an intimate opportunity for leading scientists and Tecan customers from a variety to meet and discuss emerging scientific issues related to Tecan’s fields of interest. This year, leading scientists from a variety of life sciences research organizations have joined to discuss “Biologics: From Benchtop to Production. Enabling technologies for a new era.” It covered areas including biotherapeutics, stem cell research, and regenerative medicine.
The Symposium Agenda
Tuesday, September 16th
The symposium began with a opening aperitif on the evening of September 16th. This offered the attendees an informal opportunity to meet each other, network, and catch up on their latest research activities.
Wednesday, September 17th
Thomas Bachmann, CEO, Tecan Group Ltd (Switzerland)
- Welcome and Introduction to Tecan
| Morning Session- Advances and Opportunities in Stem Cells | ||
 |
Dr. Michael West, CEO, BioTime, (USA)
|
|
 |
Dr. Takumi Era, Division of Molecular Neurobiology, Institute of Molecular Embryology and Genetics, Kumamoto University (Japan)
|
|
 |
Dr. Gerd Kempermann, Research Group Leader Molecular and Developmental Neurosciences, Centre for Regenerative Technologies (Germany)
|
|
 |
Dr. Andrew Elefanty, Head, Embryonic Stem Cell Differentiation Laboratory, Monash University (Australia)
|
|
 |
Dr. Veit Bergendahl, Senior Scientist, Cellular Dynamics International (USA)
|
|
| Afternoon Session- From Cells to Therapy | ||
 |
Dr. Lingsong Li, Professor and Director Peking University Stem Cell Research Center, Peking University Health Science Center (China)
|
|
 |
Dr. Wei-Shou Hu, Professor, University of Minnesota (USA)
|
|
 |
Dr. Stephen Minger, Director, Stem Cell Biology Laboratory, King's College, London (UK)
|
|
 |
Dr. David Haylock, Associate Professor, Australian Stem Cell Center (Australia)
|
|
Thursday, September 18thMarc Feiglin, Chief Technology Officer- Life Sciences, Corporate and Business Development, Tecan Group Ltd (USA)
|
||
| Morning Session- High Throughput Applications | ||
 |
Dr. Jürgen Hubbuch, Professor, Institut für Biotechnologie, Forschungszentrum Jülich (Germany)
|
|
 |
Mr. Alan Sawyer, Head MATF, Monash University (Australia)
|
|
 |
Dr. Lin Zhang, Associate Research Fellow, Bioprocess R&D, Pfizer (USA)
|
|
 |
Dr. Lars Branden, Director Center for High Throughput Cell Biology, Yale University (USA)
|
|
 |
Dr. Herbert Müller-Hartmann, Director R&D, amaxa AG (Germany)
|
|
| Afternoon Session- Optimization and Production of Therapeutic Proteins & Antibodies | ||
 |
Dr. Davinder Gill, Assistant Vice President, Biologic Therapeutics, Wyeth (USA)
|
|
 |
Dr. Gary Lye, Head, Advanced Centre for Biochemical Engineering, University College of London (UK)
|
|
 |
Dr. Massimo Morbidelli, Professor, ETH- Zurich (Switzerland)
|
|
 |
Dr. Majid Mehtali, VP of R&D, Vivalis (France)
|
|
Many very positive feedback was collected after the event, from the speakers and from the entire audience, encouraging Tecan to pursue ...
© 2008, Tecan Trading AG, Switzerland, all rights reserved. Disclaimer | Trademarks | Site Map